206 related articles for article (PubMed ID: 21251229)
1. Research in practice: IL-22 and IL-20: significance for epithelial homeostasis and psoriasis pathogenesis.
Sabat R; Wolk K
J Dtsch Dermatol Ges; 2011 Jul; 9(7):518-23. PubMed ID: 21251229
[TBL] [Abstract][Full Text] [Related]
2. Psoriasis and other Th17-mediated skin diseases.
Tokura Y; Mori T; Hino R
J UOEH; 2010 Dec; 32(4):317-28. PubMed ID: 21226422
[TBL] [Abstract][Full Text] [Related]
3. The immunopathogenesis of psoriasis.
Kim J; Krueger JG
Dermatol Clin; 2015 Jan; 33(1):13-23. PubMed ID: 25412780
[TBL] [Abstract][Full Text] [Related]
4. Interleukin-29 induces epithelial production of CXCR3A ligands and T-cell infiltration.
Witte E; Kokolakis G; Witte K; Warszawska K; Friedrich M; Christou D; Kirsch S; Sterry W; Volk HD; Sabat R; Wolk K
J Mol Med (Berl); 2016 Apr; 94(4):391-400. PubMed ID: 26612594
[TBL] [Abstract][Full Text] [Related]
5. The Th17 cytokine IL-22 induces IL-20 production in keratinocytes: a novel immunological cascade with potential relevance in psoriasis.
Wolk K; Witte E; Warszawska K; Schulze-Tanzil G; Witte K; Philipp S; Kunz S; Döcke WD; Asadullah K; Volk HD; Sterry W; Sabat R
Eur J Immunol; 2009 Dec; 39(12):3570-81. PubMed ID: 19830738
[TBL] [Abstract][Full Text] [Related]
6. Pathogenesis of psoriasis and development of treatment.
Ogawa E; Sato Y; Minagawa A; Okuyama R
J Dermatol; 2018 Mar; 45(3):264-272. PubMed ID: 29226422
[TBL] [Abstract][Full Text] [Related]
7. IL-22 and IL-20 are key mediators of the epidermal alterations in psoriasis while IL-17 and IFN-gamma are not.
Wolk K; Haugen HS; Xu W; Witte E; Waggie K; Anderson M; Vom Baur E; Witte K; Warszawska K; Philipp S; Johnson-Leger C; Volk HD; Sterry W; Sabat R
J Mol Med (Berl); 2009 May; 87(5):523-36. PubMed ID: 19330474
[TBL] [Abstract][Full Text] [Related]
8. Etanercept suppresses regenerative hyperplasia in psoriasis by acutely downregulating epidermal expression of interleukin (IL)-19, IL-20 and IL-24.
Wang F; Smith N; Maier L; Xia W; Hammerberg C; Chubb H; Chen C; Riblett M; Johnston A; Gudjonsson JE; Helfrich Y; Kang S; Fisher GJ; Voorhees JJ
Br J Dermatol; 2012 Jul; 167(1):92-102. PubMed ID: 22458549
[TBL] [Abstract][Full Text] [Related]
9. Pathological crosstalk in vitro between T lymphocytes and lesional keratinocytes in psoriasis: necessity of direct cell-to-cell contact.
Martin G; Guérard S; Fortin MM; Rusu D; Soucy J; Poubelle PE; Pouliot R
Lab Invest; 2012 Jul; 92(7):1058-70. PubMed ID: 22525430
[TBL] [Abstract][Full Text] [Related]
10. Interleukin (IL)-17 versus IL-27: opposite effects on tumor necrosis factor-α-mediated chemokine production in human keratinocytes.
Fujiwara S; Nagai H; Oniki S; Yoshimoto T; Nishigori C
Exp Dermatol; 2012 Jan; 21(1):70-2. PubMed ID: 22082171
[TBL] [Abstract][Full Text] [Related]
11. The Immunology of Psoriasis-Current Concepts in Pathogenesis.
Sieminska I; Pieniawska M; Grzywa TM
Clin Rev Allergy Immunol; 2024 Apr; 66(2):164-191. PubMed ID: 38642273
[TBL] [Abstract][Full Text] [Related]
12. Th17 cytokines stimulate CCL20 expression in keratinocytes in vitro and in vivo: implications for psoriasis pathogenesis.
Harper EG; Guo C; Rizzo H; Lillis JV; Kurtz SE; Skorcheva I; Purdy D; Fitch E; Iordanov M; Blauvelt A
J Invest Dermatol; 2009 Sep; 129(9):2175-83. PubMed ID: 19295614
[TBL] [Abstract][Full Text] [Related]
13. The Role of CD8+ T-Cells and their Cytokines in the Pathogenesis of Psoriasis.
Volarić I; Vičić M; Prpić-Massari L
Acta Dermatovenerol Croat; 2019 Sep; 27(3):159-162. PubMed ID: 31542059
[TBL] [Abstract][Full Text] [Related]
14. IL-17-producing CD8+ T lymphocytes from psoriasis skin plaques are cytotoxic effector cells that secrete Th17-related cytokines.
Ortega C; Fernández-A S; Carrillo JM; Romero P; Molina IJ; Moreno JC; Santamaría M
J Leukoc Biol; 2009 Aug; 86(2):435-43. PubMed ID: 19487306
[TBL] [Abstract][Full Text] [Related]
15. Monocyte-derived interferon-alpha primed dendritic cells in the pathogenesis of psoriasis: new pieces in the puzzle.
Farkas A; Kemény L
Int Immunopharmacol; 2012 Jun; 13(2):215-8. PubMed ID: 22522054
[TBL] [Abstract][Full Text] [Related]
16. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target.
Botti E; Spallone G; Caruso R; Monteleone G; Chimenti S; Costanzo A
Curr Pharm Biotechnol; 2012 Aug; 13(10):1861-7. PubMed ID: 22250707
[TBL] [Abstract][Full Text] [Related]
17. Th17 cytokines interleukin (IL)-17 and IL-22 modulate distinct inflammatory and keratinocyte-response pathways.
Nograles KE; Zaba LC; Guttman-Yassky E; Fuentes-Duculan J; Suárez-Fariñas M; Cardinale I; Khatcherian A; Gonzalez J; Pierson KC; White TR; Pensabene C; Coats I; Novitskaya I; Lowes MA; Krueger JG
Br J Dermatol; 2008 Nov; 159(5):1092-102. PubMed ID: 18684158
[TBL] [Abstract][Full Text] [Related]
18. IL-17 is produced by nickel-specific T lymphocytes and regulates ICAM-1 expression and chemokine production in human keratinocytes: synergistic or antagonist effects with IFN-gamma and TNF-alpha.
Albanesi C; Cavani A; Girolomoni G
J Immunol; 1999 Jan; 162(1):494-502. PubMed ID: 9886425
[TBL] [Abstract][Full Text] [Related]
19. Tumor necrosis factor receptor signaling in keratinocytes triggers interleukin-24-dependent psoriasis-like skin inflammation in mice.
Kumari S; Bonnet MC; Ulvmar MH; Wolk K; Karagianni N; Witte E; Uthoff-Hachenberg C; Renauld JC; Kollias G; Toftgard R; Sabat R; Pasparakis M; Haase I
Immunity; 2013 Nov; 39(5):899-911. PubMed ID: 24211183
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF antibody-induced psoriasiform skin lesions in patients with inflammatory bowel disease are characterised by interferon-γ-expressing Th1 cells and IL-17A/IL-22-expressing Th17 cells and respond to anti-IL-12/IL-23 antibody treatment.
Tillack C; Ehmann LM; Friedrich M; Laubender RP; Papay P; Vogelsang H; Stallhofer J; Beigel F; Bedynek A; Wetzke M; Maier H; Koburger M; Wagner J; Glas J; Diegelmann J; Koglin S; Dombrowski Y; Schauber J; Wollenberg A; Brand S
Gut; 2014 Apr; 63(4):567-77. PubMed ID: 23468464
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
